Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immix Biopharma, Inc.

1.87
+0.12006.86%
Post-market: 1.870.00000.00%16:24 EDT
Volume:68.22K
Turnover:122.51K
Market Cap:51.84M
PE:-2.45
High:1.88
Open:1.70
Low:1.70
Close:1.75
Loading ...
Mar 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 26, 2023

Correspondence

Form CORRESP - Correspondence
Aug 30, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Aug 23, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2023

Major Issues Report

Form 8-K - Current report